RVL Pharmaceuticals plc Selling, General and Administrative Expense
RVL Pharmaceuticals plc reported Selling, General and Administrative Expense of $13.89 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-08-14
- RVL Pharmaceuticals plc selling, general and administrative expense for the quarter ending 2023-06-30 was $13.89M, a 31.15% decline year-over-year.
- RVL Pharmaceuticals plc selling, general and administrative expense for the quarter ending 2023-03-31 was $16.20M, a 32.04% decline year-over-year.
- RVL Pharmaceuticals plc selling, general and administrative expense for the quarter ending 2022-12-31 was $17.60M, a 25.72% decline year-over-year.
- RVL Pharmaceuticals plc selling, general and administrative expense for the quarter ending 2022-09-30 was $20.38M, a 17.98% decline year-over-year.
- RVL Pharmaceuticals plc selling, general and administrative expense for fiscal 2022 was $81.98M, a 6.27% decline from fiscal 2021.
- RVL Pharmaceuticals plc selling, general and administrative expense for fiscal 2021 was $87.46M, a 20.10% increase from fiscal 2020.
- RVL Pharmaceuticals plc selling, general and administrative expense for fiscal 2020 was $72.82M.
- RVL Pharmaceuticals plc selling, general and administrative expense for fiscal 2018 was $74.24M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $13.89M 10-Q · filed 2023-08-14 | $30.08M 10-Q · filed 2023-08-14 | $47.69M derived: sum of 3 quarters · filed 2023-08-14 | $68.06M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $16.20M 10-Q · filed 2023-05-11 | $33.80M derived: sum of 2 quarters · filed 2023-05-11 | $54.17M derived: sum of 3 quarters · filed 2023-05-11 | $74.34M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $37.98M derived: sum of 2 quarters · filed 2023-03-20 | $58.15M derived: sum of 3 quarters · filed 2023-08-14 | $81.98M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $20.38M 10-Q · filed 2022-11-10 | $40.54M derived: sum of 2 quarters · filed 2023-08-14 | $64.38M 10-Q · filed 2022-11-10 | $88.07M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $20.17M 10-Q · filed 2023-08-14 | $44.00M 10-Q · filed 2023-08-14 | $67.70M derived: sum of 3 quarters · filed 2023-08-14 | $92.54M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $23.83M 10-Q · filed 2023-05-11 | $47.53M derived: sum of 2 quarters · filed 2023-05-11 | $72.37M derived: sum of 3 quarters · filed 2023-05-11 | $93.42M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $23.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $48.53M derived: sum of 2 quarters · filed 2023-03-20 | $69.58M derived: sum of 3 quarters · filed 2023-03-20 | $87.46M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $24.84M 10-Q · filed 2022-11-10 | $45.89M derived: sum of 2 quarters · filed 2022-11-10 | $63.77M 10-Q · filed 2022-11-10 | $81.64M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $21.05M 10-Q · filed 2022-08-11 | $38.00M 10-Q · filed 2022-08-11 | $38.00M 10-Q · filed 2021-08-16 | $56.80M derived: sum of 3 quarters · filed 2022-08-11 | $78.16M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $16.95M 10-Q · filed 2022-05-12 | $18.92M 10-Q · filed 2021-05-13 | $35.75M derived: sum of 2 quarters · filed 2022-05-12 | $57.11M derived: sum of 3 quarters · filed 2022-05-12 | $71.44M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $18.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $40.16M derived: sum of 2 quarters · filed 2022-03-30 | $54.49M derived: sum of 3 quarters · filed 2022-03-30 | $72.82M 10-K · filed 2022-03-30 | $81.96M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $21.36M 10-Q · filed 2021-11-15 | $23.54M 10-Q · filed 2020-11-10 | $35.70M derived: sum of 2 quarters · filed 2021-11-15 | $54.03M 10-Q · filed 2021-11-15 | $61.28M 10-Q · filed 2020-11-10 | $69.68M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $14.34M 10-Q · filed 2021-08-16 | $16.55M 10-Q · filed 2020-08-11 | $32.38M 10-Q · filed 2021-08-16 | $37.73M 10-Q · filed 2020-08-11 | $48.32M derived: sum of 3 quarters · filed 2021-09-08 | $73.07M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $21.18M 10-Q · filed 2021-05-13 | $33.98M derived: sum of 2 quarters · filed 2021-09-08 | $58.74M derived: sum of 3 quarters · filed 2021-09-08 | $84.25M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | $12.81M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $37.56M derived: sum of 2 quarters · filed 2021-09-08 | $63.07M derived: sum of 3 quarters · filed 2021-09-08 | $84.73M 8-K · filed 2021-09-08 | $93.03M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $24.75M 10-Q · filed 2020-11-10 | $24.75M 10-Q · filed 2019-11-14 | $50.26M derived: sum of 2 quarters · filed 2020-11-10 | $71.92M 10-Q · filed 2020-11-10 | $71.92M 10-Q · filed 2019-11-14 | $94.87M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $25.51M 10-Q · filed 2020-08-11 | $25.51M 10-Q · filed 2019-08-08 | $47.17M 10-Q · filed 2020-08-11 | $47.17M 10-Q · filed 2019-08-08 | $70.12M derived: sum of 3 quarters · filed 2020-08-11 | $87.57M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $21.66M 10-Q · filed 2020-05-12 | $21.66M 10-Q · filed 2019-05-09 | $44.61M derived: sum of 2 quarters · filed 2020-05-12 | $62.06M derived: sum of 3 quarters · filed 2020-05-12 | $78.74M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $40.41M derived: sum of 2 quarters · filed 2020-03-19 | $57.08M derived: sum of 3 quarters · filed 2020-03-19 | $74.24M 10-K · filed 2020-03-19 | $74.24M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $17.45M 10-Q · filed 2019-11-14 | $17.45M 10-Q · filed 2018-11-08 | $34.13M derived: sum of 2 quarters · filed 2019-11-14 | $51.29M 10-Q · filed 2019-11-14 | $66.94M derived: sum of 4 quarters · filed 2019-12-20 | |||
| 2018-06-30 | $16.68M 10-Q · filed 2019-08-08 | $33.84M 10-Q · filed 2019-08-08 | $49.49M derived: sum of 3 quarters · filed 2019-12-20 | $62.75M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-03-31 | $17.16M 10-Q · filed 2019-05-09 | $32.82M derived: sum of 2 quarters · filed 2019-12-20 | $46.07M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2017-12-31 | $15.65M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $28.91M derived: sum of 2 quarters · filed 2019-12-20 | $56.95M 8-K · filed 2019-12-20 | |||||
| 2017-09-30 | $13.26M 10-Q · filed 2018-11-08 | $41.30M 10-Q · filed 2018-11-08 |